Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

PURPOSE: Biliary tract cancers (BTCs), which include intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (EHC), and gallbladder cancer (GBC), have limited treatment options. We sought to comprehensively examine the clinical and molecular characteristics of BTCs with amplification...

詳細記述

保存先:
書誌詳細
出版年:JCO Precis Oncol
主要な著者: Mondaca, Sebastian, Razavi, Pedram, Xu, Chongrui, Offin, Michael, Myers, Mackenzie, Scaltriti, Maurizio, Hechtman, Jaclyn F., Bradley, Mikaela, O’Reilly, Eileen M., Berger, Michael F., Solit, David B., Li, Bob T., Abou-Alfa, Ghassan K.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2019
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446346/
https://ncbi.nlm.nih.gov/pubmed/32923849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00223
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料